スマートピルの世界市場の評価：タイプ別、対象領域別、用途別、適応疾患別、エンドユーザー別、地域別、機会、予測、2017年～2031年

世界のスマートピルの市場規模は、予測期間の2024年～2031年に11.51％のCAGRで拡大し、2023年の11億8,000万米ドルから2031年には28億2,000万米ドルに成長すると予測されています。市場の拡大は、低侵襲診断処置に対する患者の嗜好の高まり、スマートピル技術の技術的進歩、大腸がん患者の増加、カプセル内視鏡に対する嗜好の高まりによって支えられています。

いくつかの腸関連疾患の早期診断、食事療法、個別化医療への応用の可能性など、スマートピルに関連する様々な利点に対する意識の高まりは、市場の拡大にプラスの影響を与えています。腸のサンプリングとセンシングのための先進的なスマートピルの開発に向けた様々な研究者による取り組みの高まりも、時間効率の高い方法で幅広い疾患の診断を支援し、患者の健康をモニターすることで、臨床転帰を改善すると期待されています。2024年には、カリフォルニア大学の研究者が、胃がんや胃炎などの疾患に関連するさまざまなガスを検出できるセンサーを備え、新たに開発されたウェアラブルシステムを通じて追跡も可能なスマート錠剤を発表しました。

大腸がんの負担の増大と相まって、大腸がんの検出におけるスマートピル技術の利用が増加していることも、市場拡大を支える大きな要因です。世界保健機関（WHO）の推計によると、大腸がんは世界中で3番目に多いがんで、がん患者の約10％を占めています。スマートピルは、生理学的パラメータやバイオマーカーをモニタリングすることで、今後数年間で、がんを含むいくつかの慢性疾患の存在を示し、成功する可能性を高めると期待されています。

当レポートでは、世界のスマートピル市場について調査し、市場の概要とともに、タイプ別、対象領域別、用途別、適応疾患別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のスマートピル市場の見通し、2017年～2031年

• 市場規模と予測
• タイプ別
• 対象領域別
• 用途別
• 適応疾患別
• エンドユーザー別
• 地域別
• 企業別市場シェア（％）、2023年

第5章 世界のスマートピル市場の見通し（地域別、2017年～2031年）

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

• 供給需要分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

• Medtronic plc
• Olympus Corporation
• CapsoVision, Inc.
• Otsuka Holdings Co., Ltd.
• Medisafe
• Check-Cap Ltd.
• IntroMedic Co., Ltd.
• Koninklijke Philips N.V.
• Novartis AG
• PENTAX Medical

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 3. Global Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 4. Global Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 5. Global Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 6. Global Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 7. Global Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 8. Global Smart Pills Market Share (%), By Region, 2017-2031F
• Figure 9. North America Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 10. North America Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 11. North America Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 12. North America Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 13. North America Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 14. North America Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 15. North America Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 16. North America Smart Pills Market Share (%), By Country, 2017-2031F
• Figure 17. United States Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 18. United States Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 19. United States Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 20. United States Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 21. United States Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 22. United States Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 23. United States Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 24. Canada Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 25. Canada Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 26. Canada Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 27. Canada Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 28. Canada Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 29. Canada Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 30. Canada Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 31. Mexico Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 32. Mexico Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 33. Mexico Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 34. Mexico Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 35. Mexico Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 36. Mexico Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 37. Mexico Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 38. Europe Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 39. Europe Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 40. Europe Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 41. Europe Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 42. Europe Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 43. Europe Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 44. Europe Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 45. Europe Smart Pills Market Share (%), By Country, 2017-2031F
• Figure 46. Germany Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 47. Germany Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 48. Germany Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 49. Germany Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 50. Germany Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 51. Germany Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 52. Germany Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 53. France Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 54. France Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 55. France Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 56. France Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 57. France Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 58. France Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 59. France Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 60. Italy Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 61. Italy Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 62. Italy Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 63. Italy Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 64. Italy Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 65. Italy Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 66. Italy Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 67. United Kingdom Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 68. United Kingdom Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 69. United Kingdom Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 70. United Kingdom Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 71. United Kingdom Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 72. United Kingdom Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 73. United Kingdom Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 74. Russia Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 75. Russia Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 76. Russia Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 77. Russia Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 78. Russia Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 79. Russia Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 80. Russia Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 81. Netherlands Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 82. Netherlands Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 83. Netherlands Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 84. Netherlands Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 85. Netherlands Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 86. Netherlands Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 87. Netherlands Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 88. Spain Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 89. Spain Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 90. Spain Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 91. Spain Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 92. Spain Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 93. Spain Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 94. Spain Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 95. Turkey Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 96. Turkey Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 97. Turkey Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 98. Turkey Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 99. Turkey Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 100. Turkey Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 101. Turkey Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 102. Poland Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 103. Poland Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 104. Poland Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 105. Poland Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 106. Poland Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 107. Poland Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 108. Poland Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 109. South America Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 110. South America Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 111. South America Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 112. South America Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 113. South America Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 114. South America Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 115. South America Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 116. South America Smart Pills Market Share (%), By Country, 2017-2031F
• Figure 117. Brazil Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 118. Brazil Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 119. Brazil Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 120. Brazil Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 121. Brazil Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 122. Brazil Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 123. Brazil Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 124. Argentina Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 125. Argentina Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 126. Argentina Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 127. Argentina Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 128. Argentina Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 129. Argentina Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 130. Argentina Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 131. Asia-Pacific Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 132. Asia-Pacific Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 133. Asia-Pacific Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 134. Asia-Pacific Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 135. Asia-Pacific Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 136. Asia-Pacific Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 137. Asia- Pacific Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 138. Asia-Pacific Smart Pills Market Share (%), By Country, 2017-2031F
• Figure 139. India Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 140. India Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 141. India Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 142. India Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 143. India Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 144. India Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 145. India Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 146. China Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 147. China Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 148. China Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 149. China Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 150. China Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 151. China Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 152. China Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 153. Japan Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 154. Japan Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 155. Japan Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 156. Japan Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 157. Japan Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 158. Japan Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 159. Japan Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 160. Australia Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 161. Australia Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 162. Australia Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 163. Australia Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 164. Australia Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 165. Australia Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 166. Australia Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 167. Vietnam Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 168. Vietnam Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 169. Vietnam Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 170. Vietnam Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 171. Vietnam Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 172. Vietnam Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 173. Vietnam Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 174. South Korea Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 175. South Korea Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 176. South Korea Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 177. South Korea Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 178. South Korea Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 179. South Korea Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 180. South Korea Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 181. Indonesia Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 182. Indonesia Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 183. Indonesia Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 184. Indonesia Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 185. Indonesia Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 186. Indonesia Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 187. Indonesia Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 188. Philippines Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 189. Philippines Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 190. Philippines Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 191. Philippines Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 192. Philippines Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 193. Philippines Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 194. Philippines Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 195. Middle East & Africa Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 196. Middle East & Africa Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 197. Middle East & Africa Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 198. Middle East & Africa Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 199. Middle East & Africa Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 200. Middle East & Africa Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 201. Middle East & Africa Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 202. Middle East & Africa Smart Pills Market Share (%), By Country, 2017-2031F
• Figure 203. Saudi Arabia Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 204. Saudi Arabia Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 205. Saudi Arabia Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 206. Saudi Arabia Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 207. Saudi Arabia Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 208. Saudi Arabia Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 209. Saudi Arabia Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 210. UAE Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 211. UAE Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 212. UAE Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 213. UAE Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 214. UAE Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 215. UAE Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 216. UAE Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 217. South Africa Smart Pills Market, By Value, In USD Billion, 2017-2031F
• Figure 218. South Africa Smart Pills Market, By Volume, In Million Units, 2017-2031F
• Figure 219. South Africa Smart Pills Market Share (%), By Type, 2017-2031F
• Figure 220. South Africa Smart Pills Market Share (%), By Target Area, 2017-2031F
• Figure 221. South Africa Smart Pills Market Share (%), By Application, 2017-2031F
• Figure 222. South Africa Smart Pills Market Share (%), By Disease Indication, 2017-2031F
• Figure 223. South Africa Smart Pills Market Share (%), By End-user, 2017-2031F
• Figure 224. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 225. By Target Area Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 226. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 227. By Disease Indication Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global smart pills market is projected to witness a CAGR of 11.51% during the forecast period 2024-2031, growing from USD 1.18 billion in 2023 to USD 2.82 billion in 2031. The market's expansion is supported by the increasing patient preference for minimally invasive diagnostic procedures, technological advancements in smart pill technologies, rising cases of colorectal cancer, and a growing preference for capsule endoscopy.

The growing awareness about the various advantages associated with smart pills, including potential applications in the early diagnosis of several gut-related diseases, diet, and personalized medicine, is positively influencing the expansion of the market. The rising efforts by various researchers towards the development of advanced smart pills for sampling and sensing gut are also expected to aid in diagnosing a wide range of diseases in a time-efficient manner and monitor patient health, thus improving clinical outcomes. In 2024, researchers from the University of California introduced smart pills that are equipped with sensors that can detect different gases linked with conditions such as gastric cancer and gastritis and can also be tracked through a newly developed wearable system.

The increasing utilization of smart pill technology in the detection of colorectal cancer, coupled with the growing burden of the disease, is another major factor supporting the expansion of the market. According to the estimates of the World Health Organization (WHO), colorectal cancer is the third most common cancer across the globe and accounts for about 10% of cancer cases. Smart pills are expected to indicate the presence of several chronic diseases, including cancer, in the coming years by monitoring physiological parameters and biomarkers, boosting the chances of successful outcomes.

Technological Advancements Aid Market Growth

Technological advancements are expected to provide lucrative growth opportunities for the market in the coming years. The advancements have resulted in the incorporation of sophisticated technology in these pills, allowing them to transmit and gather a wide set of information, such as detect specific biomarkers and measure temperature and pH levels. Continuous advancements have also supported the development of microelectronic systems that have the ability to process and capture data and easily integrate into capsules while communicating with external devices such as wearables and smartphones. This allows for seamless data analysis and sharing, which aids in the development of personalized treatment plans and accurate diagnoses.

Additionally, various academic and research institutions are also focusing on technological advancements and the development of novel technologies. In 2023, researchers from California Institute of Technology successfully developed a GPS for smart pills that are capable of traveling through the human body and accurately diagnosing ailments. The technology known as Ingestible Microdevices for Anatomic-mapping of Gastrointestinal-tract (iMAG) is easy to follow and accurate. Such developments are expected to positively influence the expansion of the market in the coming years.

Increasing Preference for Non-Invasive Diagnostic Procedures Supports Market Expansion

The rising preference for non-invasive diagnostic procedures can be attributed to their ability to prioritize the safety and comfort of the patients, improving patient satisfaction and providing a positive healthcare experience. Invasive diagnostic procedures carry various risks, including damage to surrounding organs or tissue, bleeding, and infection, and can cause significant emotional distress and physical discomfort to the patient. Additionally, the market is also witnessing significant growth due to the growing popularity of different applications of smart pills, including capsule endoscopy, that offer a wide range of benefits to both patients and healthcare professionals. Capsule endoscopy is used for diagnosing a wide range of diseases and disorders, including celiac disease, gastrointestinal bleeding, ulcerative colitis, Crohn's disease, and colon and rectal cancer, among others.

North America is Expected to Account for Significant Market Share

The growth of the market in the region is supported by the expansion of the healthcare sector in the region, strong presence of key market players, high acceptance rate of new technologies, and increasing incidences of chronic diseases. Additionally, the rising investments towards research and development activities are bolstering the growth of the market in North America. In June 2024, a team of researchers from the USC Viterbi School of Engineering, California, United States, developed an ingestible sensor for providing real-time location tracking and detecting stomach gases. The membranes of the capsules are designed from materials that change their behavior when they come in contact with ammonia gas. Ammonia is a component of H pylori, a type of gut bacteria whose elevated levels can be indicators of irritable bowel syndrome, peptic ulcers, and gastric cancer. Such inventions are expected to aid in the early detection of different types of diseases, including gastric cancer. As per the estimates of the American Cancer Society, approximately 26,890 new cases of gastric cancer and 10,880 deaths because of the disease are expected to occur in the United States in 2024. They also estimate that gastric cancer accounts for approximately 1.5% of the new cancer cases that are diagnosed in the United States every year. Thus, providing lucrative growth opportunities to the market and supporting its expansion in North America.

Hospitals are Anticipated to Hold Significant Share of the Market

The growing adoption of smart pills by hospitals can be attributed to the different advantages associated with their usage such as their ability to continuously monitor vital signs including temperature and heart rate and transmit the collected data to healthcare professionals. Due to this, healthcare professionals are able to detect abnormalities earlier and intervene in a time-efficient manner, which in turn improves patient outcomes and reduces the requirement for frequent hospital visits. The real-time monitoring of patient health allows healthcare providers to ensure that the treatment regime is being followed and alter the treatment plan depending upon their progress, thus propelling their requirements from hospitals to enhance patient experience and prevent various complications.

Furthermore, the rising investments, partnerships, and initiatives to support the construction of smart hospitals and the upgradation of existing ones are other major factors boosting the segment's expansion. In March 2024, the Greek government announced a 400 million upgrade for 156 health centers and 80 hospital units. The initiative includes the acquisition of medical equipment, reform implementation, and infrastructure improvements, and it aims to improve the healthcare system for patients. Such investments and initiatives are expected to propel the requirement for advanced medical devices from hospitals, including smart pills, bolstering the global smart pills market growth.

Future Market Scenario (2024-2031F)

Smart pills are expected to revolutionize the way in which various diseases and disorders are treated and monitored in the coming years. They can target drug delivery and release medications at specific locations with the help of microfluidic systems, thus improving the efficacy of treatments and reducing side effects. They can also provide real-time data on the rate of drug absorption, aiding physicians in making personalized adjustments to the dosage of drugs.

As per the global smart pills market analysis, the rising cases of cancer are also expected to provide lucrative growth opportunities to the market as smart pill technology has the potential to aid cancer treatment and diagnosis with the help of specific biomarker sensors. Due to this, the smart pills could monitor the effectiveness of the treatment in real-time and detect early signs of cancer, enabling swift intervention and boosting the chances of successful outcomes.

The technology is also expected to aid healthcare professionals in addressing the issue of medication errors by monitoring if medication is missed, which in turn will ensure that the therapeutic benefits of the medication are achieved, and the risks associated with medication error are avoided.

Key Players Landscape and Outlook

The increasing efforts of the key players of the market towards research and development activities are boosting the global smart pills market size. Such activities aid market players in evaluating the safety and efficacy of different technologies, allowing them to receive approval from various regulatory bodies. In May 2024, Medtronic's PillCam Genius SB capsule kit received 510 (k) clearance from the FDA. The new technology comprises a link device and a pill that adheres to the abdomen of the patient and replaces the requirement of a sensor belt and data recorder. This clearance will ensure patients experience comfort by eliminating the requirement for a bulky recorder, supporting the market's expansion.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Smart Pills Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By Type
  • 4.2.1. Product
  • 4.2.2. Tools
  • 4.2.3. Patient Monitoring Software
• 4.3. By Target Area
  • 4.3.1. Esophagus
  • 4.3.2. Small Intestine
  • 4.3.3. Large Intestine
  • 4.3.4. Stomach
• 4.4. By Application
  • 4.4.1. Capsule Endoscopy
  • 4.4.2. Targeted Drug Delivery
  • 4.4.3. Vital Sign Monitoring
• 4.5. By Disease Indication
  • 4.5.1. Celiac Disease
  • 4.5.2. Crohn's Disease
  • 4.5.3. Neurological Disorder
  • 4.5.4. Occult GI Bleeding
  • 4.5.5. Small Bowel Tumors
  • 4.5.6. Others
• 4.6. By End-user
  • 4.6.1. Hospitals
  • 4.6.2. Diagnostic Centers
  • 4.6.3. Others
• 4.7. By Region
  • 4.7.1. North America
  • 4.7.2. South America
  • 4.7.3. Europe
  • 4.7.4. Asia-Pacific
  • 4.7.5. Middle East and Africa
• 4.8. By Company Market Share (%), 2023

5. Global Smart Pills Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
    • 5.1.1.2. By Volume
  • 5.1.2. By Type
    • 5.1.2.1. Product
    • 5.1.2.2. Tools
    • 5.1.2.3. Patient Monitoring Software
  • 5.1.3. By Target Area
    • 5.1.3.1. Esophagus
    • 5.1.3.2. Small Intestine
    • 5.1.3.3. Large Intestine
    • 5.1.3.4. Stomach
  • 5.1.4. By Application
    • 5.1.4.1. Capsule Endoscopy
    • 5.1.4.2. Targeted Drug Delivery
    • 5.1.4.3. Vital Sign Monitoring
  • 5.1.5. By Disease Indication
    • 5.1.5.1. Celiac Disease
    • 5.1.5.2. Crohn's Disease
    • 5.1.5.3. Neurological Disorder
    • 5.1.5.4. Occult GI Bleeding
    • 5.1.5.5. Small Bowel Tumors
    • 5.1.5.6. Others
  • 5.1.6. By End-user
    • 5.1.6.1. Hospitals
    • 5.1.6.2. Diagnostic Centers
    • 5.1.6.3. Others
  • 5.1.7. United States*
    • 5.1.7.1. Market Size & Forecast
      • 5.1.7.1.1. By Value
      • 5.1.7.1.2. By Volume
    • 5.1.7.2. By Type
      • 5.1.7.2.1. Product
      • 5.1.7.2.2. Tools
      • 5.1.7.2.3. Patient Monitoring Software
    • 5.1.7.3. By Target Area
      • 5.1.7.3.1. Esophagus
      • 5.1.7.3.2. Small Intestine
      • 5.1.7.3.3. Large Intestine
      • 5.1.7.3.4. Stomach
    • 5.1.7.4. By Application
      • 5.1.7.4.1. Capsule Endoscopy
      • 5.1.7.4.2. Targeted Drug Delivery
      • 5.1.7.4.3. Vital Sign Monitoring
    • 5.1.7.5. By Disease Indication
      • 5.1.7.5.1. Celiac Disease
      • 5.1.7.5.2. Crohn's Disease
      • 5.1.7.5.3. Neurological Disorder
      • 5.1.7.5.4. Occult GI Bleeding
      • 5.1.7.5.5. Small Bowel tumors
      • 5.1.7.5.6. Others
    • 5.1.7.6. By End-user
      • 5.1.7.6.1. Hospitals
      • 5.1.7.6.2. Diagnostic Centers
      • 5.1.7.6.3. Others
  • 5.1.8. Canada
  • 5.1.9. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. Asia-Pacific
  • 5.3.1. India
  • 5.3.2. China
  • 5.3.3. Japan
  • 5.3.4. Australia
  • 5.3.5. Vietnam
  • 5.3.6. South Korea
  • 5.3.7. Indonesia
  • 5.3.8. Philippines
• 5.4. South America
  • 5.4.1. Brazil
  • 5.4.2. Argentina
• 5.5. Middle East and Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Type
• 6.2. By Target Area
• 6.3. By Application
• 6.4. By Disease Indication
• 6.5. By End-user
• 6.6. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat From New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Patent Landscape
• 9.2. Regulatory Approvals
• 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Medtronic plc
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products and Services
  • 13.1.4. Financials (As Reported)
  • 13.1.5. Key Market Focus and Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Olympus Corporation
• 13.3. CapsoVision, Inc.
• 13.4. Otsuka Holdings Co., Ltd.
• 13.5. Medisafe
• 13.6. Check-Cap Ltd.
• 13.7. IntroMedic Co., Ltd.
• 13.8. Koninklijke Philips N.V.
• 13.9. Novartis AG
• 13.10. PENTAX Medical

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14. Strategic Recommendations

15. About Us & Disclaimer